CClinicalTrials.gg
CompletedNCT00470106IBASCUpdated Apr 22, 2016Results posted

Improving Basic and Social Cognition in Veterans With Schizophrenia

An interventional study of Cognitive remediation and Social Cognitive skills training in Schizoaffective Disorder and Schizophrenia, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2016-04-22.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
85
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Veterans with schizophrenia and schizoaffective disorder experience very high levels of disability and poor community outcome. Further improvements in community outcome for patients with these disorders will not occur simply through better control of clinical symptoms. Instead, it will be necessary to find treatments that address the key determinants of poor functional outcome. Evidence strongly suggests that basic (non-social) cognitive and social cognitive deficits are among the key determinants of functional outcome for these illnesses. The primary goal of this 2-year pilot study is to implement and validate a new remediation program for social cognition that is appropriate for veterans with schizophrenia and schizoaffective disorder.

Read the detailed description

Veterans with schizophrenia and schizoaffective disorder experience very high levels of disability and poor community outcome. Further improvements in community outcome for patients with these disorders will not occur simply through better control of clinical symptoms. Instead, it will be necessary to find treatments that address the key determinants of poor functional outcome. Evidence strongly suggests that basic (non-social) cognitive and social cognitive deficits are among the key determinants of functional outcome for these illnesses. The primary goal of this 2-year pilot study is to implement and validate a new remediation program for social cognition that is appropriate for veterans with schizophrenia and schizoaffective disorder.

We plan to recruit 72 patients over the 2 years of the study from the outpatient clinics at the VA Greater Los Angeles Healthcare System (VAGLAHS). They will receive baseline assessment that includes measures of social cognition, basic cognition, electrophysiology, functional capacity, clinical symptoms, community status, and demographics / clinical history. Follow up assessments will be administered at the mid-point of training (at 6 weeks) and end of training (at 12 weeks). Each follow up assessment will include measures of basic cognition, social cognition, electrophysiology, functional capacity, and clinical symptoms. The tester administering the assessments will be blind to treatment group.

Subjects will be randomly assigned to one of four groups: 1) social cognitive training, 2) basic cognitive remediation, 3) a combined social cognitive and basic cognitive intervention, or 4) social skills training. All groups will meet in one-hour sessions held twice a week over the course of 12 weeks in small groups of 3-6. The Social Cognition Intervention (SCI) is a new 24-session, manualized intervention program specifically designed to improve emotion perception, social context processing, and theory of mind / attributional bias in veterans with schizophrenia and schizoaffective disorder. The Basic Cognitive Intervention (BCI) will involve computer-assisted training exercises. Each participant will work individually on a notebook computer. The combined intervention will cover the same content areas as the social cognitive and basic cognitive interventions, but will not go into as much detail as the separate intervention programs. The control condition will be facilitated discussion of current events. Treatment will be administered in a group format with three to six patients and a training coach.

02

Conditions studied

  • Schizoaffective Disorder
  • Schizophrenia

Keywords

  • Cognition
  • Remediation
  • Schizophrenia
  • Social Cognition
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 85 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients must be diagnosed with Schizophrenia, Schizoaffective Disorder, or Psychosis not otherwise specified according to Diagnosis and Statistical Manual-IV criteria.
  • In addition, the subjects will meet the following criteria:

    • Between 18 and 60 years of age
    • Estimated premorbid intelligence quotient > 70 (based on reading ability)
    • Understand spoken English sufficiently to comprehend testing procedures
    • Clinically stable (e.g., no inpatient hospitalization in the 8 weeks prior to enrollment, no significant changes in medication in the 6 weeks prior to enrollment, and none anticipated for the 3 months of participation)

Exclusion criteria

Exclusion Criteria:

  • No clinically significant neurological disease as determined by medical history
  • No history of serious head injury (e.g., loss of consciousness longer than 1 hour)
  • No physical, cognitive, or language impairment of such severity as to adversely affect the validity of data
  • No evidence of drug or alcohol dependence in the past six months, and not intoxicated at time of testing
  • The patients psychotic experiences can be explained solely by the use of drugs or alcohol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
85 participants (actual)

Study arms

  • Active comparator
    Cognitive Remediation

    cognitive remediation

    Behavioral: Cognitive remediation

  • Experimental
    Social Cognitive Skills Training

    social cognitive skills training

    Behavioral: Social Cognitive skills training

  • Active comparator
    Hybrid Intervention

    combined social cognitive and cognitive remediation training

    Behavioral: hybrid intervention

  • Other
    Skills Training

    control training

    Behavioral: skills training

Interventions

  • BehavioralCognitive remediation

    Computer exercises in attention, memory, and speed of processing.

  • BehavioralSocial Cognitive skills training

    Group training on emotion perception, social perception, and understanding others' mental states.

  • Behavioralhybrid intervention

    A combination of the two groups listed above.

  • Behavioralskills training

    Skills training in how to identify symptoms of illness and medication side effects.

06

What researchers measure

Primary outcomes

  1. Mean Test Scores for Facial Emotion Identification.

    This is a test of social cognition that measures the ability to identify the emotion shown in photos of still faces. The construct of interest is facial affect perception. It is an experimental measure and does not have norms or cut-offs. The range of accuracy scores is 0-56 with higher being better.

    Time frame: Assessments for end point (12 weeks).

Secondary outcomes

  1. Mean Test Score From a Test of Functional Capacity (Ability to Perform Daily Activities).

    This is a role play demonstration test that measures how well someone handles social communication in daily life. The scores reflect overall effectiveness and are the mean number scored across different social situations with a range of 0-5 with higher being better. There are no norms for this test.

    Time frame: Assessments at endpoint (12 weeks).

07

Results

Posted Apr 22, 2016

Participant flow

Participants were recruited from outpatient clinics at VA Greater Los Angeles Health care system and local mental health facilities. All patients met Diagnostic and Statistical Manual-IV criteria for schizophrenia, schizoaffective disorder, delusional disorder, or psychosis not otherwise specified (not secondary to substance use disorder)

Participant flow — Overall Study
MilestoneSocial CognitionCognitive RemediationHybrid GroupControl - Social Skills Training
Started19242121
Completed16191419
Not completed3572

Outcome measures

PrimaryMean Test Scores for Facial Emotion Identification.

This is a test of social cognition that measures the ability to identify the emotion shown in photos of still faces. The construct of interest is facial affect perception. It is an experimental measure and does not have norms or cut-offs. The range of accuracy scores is 0-56 with higher being better.

Time frame:
Assessments for end point (12 weeks).
Reported as:
Mean · number of correct answers
Mean Test Scores for Facial Emotion Identification.
number of correct answersSocial Cognitive Skills TrainingCognitive RemediationHybrid InterventionSkills Training
Mean Test Scores for Facial Emotion Identification.45.5 ± 8.241.1 ± 12.143.8 ± 6.745.1 ± 5.0
Statistical analysis
  • Social Cognitive Skills Training vs Cognitive Remediation vs Hybrid Intervention vs Skills Training · mixed model · p = <.001 (Not corrected for multiple comparisons because it is primary.)same analysis as for secondary outcome variable.
SecondaryMean Test Score From a Test of Functional Capacity (Ability to Perform Daily Activities).

This is a role play demonstration test that measures how well someone handles social communication in daily life. The scores reflect overall effectiveness and are the mean number scored across different social situations with a range of 0-5 with higher being better. There are no norms for this test.

Time frame:
Assessments at endpoint (12 weeks).
Reported as:
Mean · number correct
Mean Test Score From a Test of Functional Capacity (Ability to Perform Daily Activities).
number correctSocial CognitionCognitive RemediationHybrid GroupControl - Social Skills Training
Mean Test Score From a Test of Functional Capacity (Ability to Perform Daily Activities).3.43 ± .783.57 ± .743.35 ± 1.113.19 ± .86
Statistical analysis
  • Social Cognition vs Cognitive Remediation vs Hybrid Group vs Control - Social Skills Training · mixed model · p = <.10 (A priori threshold for significance was P \< .05)Same as for the primary variable.

Adverse events

Collected over October 2007 to September 2009. Non-serious events are listed at a 2% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Social Cognition—0/19 (0%)0/19 (0%)
Cognitive Remediation—1/24 (4.2%)0/24 (0%)
Hybrid Group—2/21 (9.5%)1/21 (4.8%)
Control - Social Skills Training—3/21 (14.3%)0/21 (0%)
Most frequent serious events
Most frequent serious events
EventSocial CognitionCognitive RemediationHybrid GroupControl - Social Skills Training
5150 hold for suicidal thinking, aggressive behavior and exessive use of alcoholPsychiatric disorders0/190/241/210/21
5150 hold for relapse using cocaine and alcoholPsychiatric disorders0/190/240/211/21
5150 for threatening to sexually assault a female VeteranPsychiatric disorders0/190/241/210/21
Subject was hospitalized for 8 days due to an inflammed pancreas.Endocrine disorders0/190/240/211/21
5150 hold for aggressive argument with his mother.Psychiatric disorders0/190/240/211/21
MRSA cellulitis in both hands.Skin and subcutaneous tissue disorders0/191/240/210/21
Most frequent other events
Most frequent other events
EventSocial CognitionCognitive RemediationHybrid GroupControl - Social Skills Training
ER visit for public intoxication.Psychiatric disorders0/190/241/210/21

Baseline characteristics

Age, Continuous
Age, Continuous(years)Social CognitionCognitive RemediationHybrid GroupControl - Social Skills TrainingTotal
Mean51.0 ± 7.146.6 ± 7.450.4 ± 10.145.1 ± 11.248.4 ± 8.6
Sex: Female, Male
Sex: Female, Male(Participants)Social CognitionCognitive RemediationHybrid GroupControl - Social Skills TrainingTotal
Female12148
Male1517131560
Region of Enrollment
Region of Enrollment(participants)Social CognitionCognitive RemediationHybrid GroupControl - Social Skills TrainingTotal
United States1619141968
Affect perception
Affect perception(number of correct answers)Social CognitionCognitive RemediationHybrid GroupControl - Social Skills TrainingTotal
Mean37.1 ± 6.140.6 ± 8.438.6 ± 8.343.4 ± 3.739.8 ± 7.0
08

Study locations

1 site
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA
    West Los Angeles, California 90073, United States
09

References and documents

Publications

  • Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, Marder SR, Green MF. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res. 2011 Aug;45(8):1113-22. doi: 10.1016/j.jpsychires.2011.01.015. Epub 2011 Mar 4. PubMed 21377168 ↗

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00470106
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
May 7, 2007
Start date
Sep 2007
Primary completion
Sep 2009
Completion
Sep 2009
Results posted
Apr 22, 2016
Last update
Apr 22, 2016

Study contacts

Michael F Green, PhD
principal investigator · VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion